Nipocalimab, an FcRn blocker, receives FDA Fast Track status for SLE treatment after demonstrating significant improvements in disease activity.

In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.

Anifrolumab, a type I interferon receptor antagonist, is already approved as an intravenous (IV) therapy for SLE. The TULIP-SC trial was designed to evaluate whether a weekly subcutaneous (SC) ...

A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus erythematosus (SLE), a complex autoimmune disease affecting multiple ...

Study: An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Image Credit: Shit4Sell / Shutterstock.com In a recent study ...

Objective Systemic lupus erythematosus (SLE) is associated with increased susceptibility to infections, including herpes ...

WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest. “The ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Fate Therapeutics (FATE). The reason why I want to go over this biotech next is because it is ...

First Nations, Métis and Inuit people with primary biliary cholangitis—a debilitating autoimmune liver disease—have more advanced symptoms at diagnosis and worse long-term outcomes than others in ...

Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer medication teclistamab. Not ...